avril 2022

Vyant Bio

Vyant Bio

Sole Agent (ATM Offering)

Canaccord Genuity Acted as Sole Agent to Vyant Bio on its $20 Million At-the-Market Offering

More Like This

US$92m

décembre 2024

Candel Therapeutics

Joint Bookrunner (CMPO)
décembre 2024

Neuronetics

Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
novembre 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma

Afficher les transactions Healthcare